Concepedia

Allison P. Jacob

AP

Statistics

Publications

24

Citations

2K

H-Index

17

Active since

1994

Affiliations

Adaptive Biotechnologies (United States)(Current)

Center for Cancer Research

Amgen (United States)

Stanford University

National Cancer Institute

Allison P. Jacob is an author at Adaptive Biotechnologies (United States) specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

1994–2024

24

Publications

24

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

Eva González‐Suárez, Allison P. Jacob, Jon C. Jones et al. · Nature · 2010 · 583 citations

, , +6

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Matthew J. Frank, Nasheed Hossain, Ali Bukhari et al. · Journal of Clinical Oncology · 2021 · 143 citations · Full text

SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel et al. · Cancer Research · 2015 · 128 citations

, , +15

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

John H. Baird, Matthew J. Frank, Juliana Craig et al. · Blood · 2020 · 80 citations · Full text

1–5 of 24